Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Two in vitro studies, DPRA and LuSens were ran to assess the skin sensitisation potency of the test substance in a weight of evidence approach. The 2 studies conducted represent 2 key events in the adverse outcome pathway: DPRA representing the 1st key event (peptide reactivity) and LuSens the 2nd key event (keratinocyte response). Both studies show no indication that the test item might be skin sensitizing, therefore it was concluded to not classify the substance as skin sensitising.

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)

Justification for classification or non-classification

Regarding the classification of the substance for skin sensitisation the results of the two individual assays of the in vitro skin sensitisation test battery need to be taken together as they reflect 2 key events in the adverse outcome pathway leading to skin sensitisation. For this reason, a weight of evidence approach is applied for the test battery stating that: 'any two of the three tests determine the overall results, i.e. any two positive results drive the prediction of a sensitizer, while any two negative results drive the prediction of a test substance to be a non-sensitizer'.

Negative results were obtained both in the DPRA and in the LuSens studies, leading to the conclusion that the substance is not skin sensitising.